Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3

Todd Neale

December 09, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

ECLIPSE: Balloon Angioplasty as Good as Orbital Atherectomy in Calcified Lesions

News Conference News TCT 2024

ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

Advertisement

Top Coronary Artery Disease News in 2024

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

MACE in CV Trials: Has the Outcome Outlived Its Role?

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

Little Pre- and Postmarket Testing for Most Recalled CV Devices

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

DES Best for In-Stent Restenosis, but DCBs Also Viable

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content